Pharmacologic management of heart failure: positive inotropic agents (Q72748511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

title

Pharmacologic management of heart failure: positive inotropic agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Cross JA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

Critical Care Nursing Clinics of North America

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

589-597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

Chronic congestive heart failure. Where have we been? Where are we heading?

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Effects of enoximone on quality of life

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Effect of digitalis treatment on survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Evaluating the efficacy of new inotropic agents

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Digitalis and neurohormonal abnormalities in heart failure and implications for therapy

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Review of randomized trials of digoxin therapy in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Acute congestive heart failure: pharmacologic intervention.

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Current status of non-digitalis positive inotropic drugs

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Acute effects of intravenous phosphodiesterase inhibition in chronic heart failure: simultaneous pre- and afterload reduction with a single agent

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Pathophysiology of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Pathophysiology and current therapy of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Dopaminergic drugs in the management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Outpatient Dobutamine Therapy: The Rhyme and the Riddle

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Part I Digitalis glycosides: Mechanisms and manifestations of toxicity

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Part II Digitalis glycosides: Mechanisms and manifestations of toxicity

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Tolerance to dobutamine after a 72 hour continuous infusion

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Pharmacodynamics of enoximone during intravenous infusion

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0899-5885(18)30527-6

7 January 2021

10.1016/S0899-5885(18)30527-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8297549 AND SRC:MED&resulttype=core&format=json

28 October 2019

1 reference